Cargando…

Cardiomyocyte Regeneration

The heart was initially believed to be a terminally differentiated organ; once the cardiomyocytes died, no recovery could be made to replace the dead cells. However, around a decade ago, the concept of cardiac stem cells (CSCs) in adult hearts was proposed. CSCs differentiate into cardiomyocytes, ke...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawaguchi, Nanako, Nakanishi, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972659/
https://www.ncbi.nlm.nih.gov/pubmed/24709645
http://dx.doi.org/10.3390/cells2010067
_version_ 1782309607877640192
author Kawaguchi, Nanako
Nakanishi, Toshio
author_facet Kawaguchi, Nanako
Nakanishi, Toshio
author_sort Kawaguchi, Nanako
collection PubMed
description The heart was initially believed to be a terminally differentiated organ; once the cardiomyocytes died, no recovery could be made to replace the dead cells. However, around a decade ago, the concept of cardiac stem cells (CSCs) in adult hearts was proposed. CSCs differentiate into cardiomyocytes, keeping the heart functioning. Studies have proved the existence of stem cells in the heart. These somatic stem cells have been studied for use in cardiac regeneration. Moreover, recently, induced pluripotent stem cells (iPSCs) were invented, and methodologies have now been developed to induce stable cardiomyocyte differentiation and purification of mature cardiomyocytes. A reprogramming method has also been applied to direct reprogramming using cardiac fibroblasts into cardiomyocytes. Here, we address cardiomyocyte differentiation of CSCs and iPSCs. Furthermore, we describe the potential of CSCs in regenerative biology and regenerative medicine.
format Online
Article
Text
id pubmed-3972659
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-39726592014-04-07 Cardiomyocyte Regeneration Kawaguchi, Nanako Nakanishi, Toshio Cells Review The heart was initially believed to be a terminally differentiated organ; once the cardiomyocytes died, no recovery could be made to replace the dead cells. However, around a decade ago, the concept of cardiac stem cells (CSCs) in adult hearts was proposed. CSCs differentiate into cardiomyocytes, keeping the heart functioning. Studies have proved the existence of stem cells in the heart. These somatic stem cells have been studied for use in cardiac regeneration. Moreover, recently, induced pluripotent stem cells (iPSCs) were invented, and methodologies have now been developed to induce stable cardiomyocyte differentiation and purification of mature cardiomyocytes. A reprogramming method has also been applied to direct reprogramming using cardiac fibroblasts into cardiomyocytes. Here, we address cardiomyocyte differentiation of CSCs and iPSCs. Furthermore, we describe the potential of CSCs in regenerative biology and regenerative medicine. MDPI 2013-01-15 /pmc/articles/PMC3972659/ /pubmed/24709645 http://dx.doi.org/10.3390/cells2010067 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Kawaguchi, Nanako
Nakanishi, Toshio
Cardiomyocyte Regeneration
title Cardiomyocyte Regeneration
title_full Cardiomyocyte Regeneration
title_fullStr Cardiomyocyte Regeneration
title_full_unstemmed Cardiomyocyte Regeneration
title_short Cardiomyocyte Regeneration
title_sort cardiomyocyte regeneration
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972659/
https://www.ncbi.nlm.nih.gov/pubmed/24709645
http://dx.doi.org/10.3390/cells2010067
work_keys_str_mv AT kawaguchinanako cardiomyocyteregeneration
AT nakanishitoshio cardiomyocyteregeneration